AVEO Pharmaceuticals, Inc. AVEO
15.00 +15.00
Day range unavailable
52-week range unavailable
News
businesswire.com Arcus Biosciences Announces Clinical Supply Agreement with AVEO Oncology to Evaluate Casdatifan in Combination with Tivozanib for Advanced Kidney Cancer Patients HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE: RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for…
reuters.com Natera, Aveta partner on late-stage head and neck cancer trial Genetic testing firm Natera and cancer drug developer Aveta Biomics said on Monday they have partnered on a late-stage study of an experimental therapy for head and neck cancer, in a bid to improve…
globenewswire.com CORRECTION – AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee – Industry veteran brings extensive clinical development experience to AVEO Oncology leadership team as Chief Medical Officer –
globenewswire.com AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee – Industry veteran brings extensive clinical development experience to AVEO Oncology leadership team as Chief Medical Officer –
globenewswire.com AVEO Oncology Announces Publication of Long-Term Survival in Patients With Relapsed/Refractory Advanced Renal Cell Carcinoma Treated With Tivozanib: Analysis of the Phase III TIVO-3 Trial in The Oncologist BOSTON, Feb. 06, 2024 (GLOBE NEWSWIRE) -- AVEO Oncology , an LG Chem company (“AVEO”), today announced The Oncologist has published a post-hoc analysis of long-term progression free survival, overall…
globenewswire.com AVEO Oncology Enrolls First Patient in Pivotal FIERCE-HN Clinical Trial to Evaluate Ficlatuzumab in Combination with ERBITUX® (cetuximab) in Patients with HPV-negative Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) BOSTON, Jan. 16, 2024 (GLOBE NEWSWIRE) -- AVEO Oncology (“AVEO”), an LG Chem company, today announced enrollment of the first patient in the FIERCE-HN trial, a global, multicenter, randomized,…
zacks.com 4 Drug Stocks That More Than Doubled This Year We present four biotech stocks, AVEO, CABA, VRNA and WVE, which despite the current volatile market, have provided more than twice the returns in 2022.
zacks.com Are Medical Stocks Lagging AVEO Pharmaceuticals (AVEO) This Year? Here is how AVEO Pharmaceuticals (AVEO) and Merit Medical (MMSI) have performed compared to their sector so far this year.
zacks.com AVEO Oncology (AVEO): Strong Industry, Solid Earnings Estimate Revisions AVEO Oncology (AVEO) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
zacks.com What Makes AVEO Pharmaceuticals (AVEO) a Strong Momentum Stock: Buy Now? Does AVEO Pharmaceuticals (AVEO) have what it takes to be a top stock pick for momentum investors? Let's find out.
zacks.com AVEO Pharmaceuticals (AVEO) Reports Q3 Loss, Tops Revenue Estimates AVEO (AVEO) delivered earnings and revenue surprises of 43.75% and 1.67%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
zacks.com AVEO Pharmaceuticals (AVEO) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release AVEO (AVEO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
zacks.com AVEO Oncology (AVEO) to Report Q3 Earnings: Is a Beat in Store? AVEO Oncology's (AVEO) third-quarter earnings is expected to reflect strong Fotivda sales. The company is likely to beat the Zacks Consensus Estimate.
zacks.com Are Medical Stocks Lagging AVEO Pharmaceuticals (AVEO) This Year? Here is how AVEO Pharmaceuticals (AVEO) and Akero Therapeutics, Inc. (AKRO) have performed compared to their sector so far this year.
benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2022 Upgrades
pulse2.com Why LG Chem Is Buying AVEO Oncology (AVEO) For $566 Million LG Chem is buying AVEO Oncology for $566 million. These are the details.
schaeffersresearch.com Biopharma Stock Soaring on Buyout News Aveo Pharmaceuticals Inc (NASDAQ:AVEO) stock is soaring today, up 40.7% at $14.74 at last glance, after news that South Korean chemical company LG Chem plans to buy the biopharmaceutical name for $15…
investors.com Aveo Stock Continues Its Bullish Run After Snagging $566 Million LG Chem Buyout Aveo Oncology agreed to be acquired by Korea's LG Chem on Tuesday, and Aveo stock skyrocketed to a near two-year high on the news. The post Aveo Stock Continues Its Bullish Run After Snagging $566…
investorplace.com What Is Going on With AVEO Pharmaceuticals (AVEO) Stock Today? AVEO Oncology (NASDAQ: AVEO ) stock jumped 40% in premarket trading after LG Chem (OTCMKTS:LGCLF) said it would buy the company for $15/share in cash. The price implies a value of $566 million for…
zacks.com 3 Breakout Stocks to Keep an Eye on for Solid Returns Par Pacific (PARR), AVEO Pharmaceuticals (AVEO) and Heritage Commerce Corp (HTBK) have been selected as the breakout stocks for today.
zacks.com Is AVEO Pharmaceuticals (AVEO) Stock Outpacing Its Medical Peers This Year? Here is how AVEO Pharmaceuticals (AVEO) and Trevi Therapeutics, Inc. (TRVI) have performed compared to their sector so far this year.
benzinga.com Earnings Scheduled For August 4, 2022 Companies Reporting Before The Bell • Toyota Motor (NYSE:TM) is projected to report earnings for its first quarter.
benzinga.com Earnings Scheduled For May 5, 2022 Companies Reporting Before The Bell • Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.
benzinga.com 68 Biggest Movers From Yesterday Gainers Sonim Technologies, Inc. (NASDAQ: SONM) shares jumped 103.3% to settle at $1.22 on Tuesday after the company announced its XP8 smartphone has integrated with the Walkie Talkie in Microsoft…
benzinga.com 38 Stocks Moving In Tuesday's Mid-Day Session Gainers- benzinga.com 96 Biggest Movers From Yesterday Gainers Volt Information Sciences, Inc. (NYSE: VOLT) shares surged 94.7% to close at $5.88 on Monday after the company announced it would be acquired for $6 per share.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday During Wednesday's morning trading, 400 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Friday During Friday's session, 445 companies made new 52-week lows.
- benzinga.com Earnings Scheduled For November 8, 2021 Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $0.11 per share on revenue of $215.14 million.
benzinga.com Earnings Scheduled For August 5, 2021 Companies Reporting Before The Bell • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million.
benzinga.com Earnings Scheduled For May 10, 2021 Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its first quarter. • Bluegreen Vacations (NYSE:BVH) is expected to report earnings for its first quarter.- benzinga.com 76 Biggest Movers From Yesterday Gainers
- benzinga.com 60 Stocks Moving In Thursday's Mid-Day Session Gainers Entera Bio Ltd. (NASDAQ: ENTX) shares jumped 284% to $6.15 after the company disclosed positive topline EB613 Phase 2 biomarker data.
benzinga.com Stocks That Hit 52-Week Highs On Thursday On Thursday morning, 420 companies hit new 52-week highs.
benzinga.com 38 Stocks Moving in Thursday's Pre-Market Session Gainers Nova LifeStyle, Inc. (NASDAQ: NVFY) shares rose 195.4% to $7.09 in pre-market trading.- benzinga.com Stocks That Hit 52-Week Highs On Tuesday On Tuesday, 118 companies set new 52-week highs.
- benzinga.com Stocks That Hit 52-Week Highs On Wednesday During Wednesday's morning session, 85 stocks hit new 52-week highs.
- benzinga.com Stocks That Hit 52-Week Highs On Monday During the morning session on Monday, 120 stocks hit new 52-week highs.
benzinga.com 72 Biggest Movers From Yesterday Gainers Stemline Therapeutics, Inc (NASDAQ: STML) shares climbed 154.8% to close at $12.10 on Monday after the company agreed to be acquired y Menarini Group in a transaction valued at up to $677…- benzinga.com 55 Stocks Moving In Monday's Mid-Day Session Gainers Stemline Therapeutics, Inc (NASDAQ: STML) shares jumped 154% to $12.06 after the company agreed to be acquired y Menarini Group in a transaction valued at up to $677 million.
- benzinga.com 72 Biggest Movers From Yesterday Gainers ThermoGenesis Holdings, Inc. (NASDAQ: THMO) shares jumped 58.1% to close at $11.49 on Thursday after falling 10% on Wednesday.
- benzinga.com 61 Stocks Moving In Thursday's Mid-Day Session Gainers AgEagle Aerial Systems, Inc. (NASDAQ: UAVS) shares climbed 76.1% to $4.05 after jumping 160% on Wednesday.
- benzinga.com Stocks That Hit 52-Week Lows On Friday
- benzinga.com 50 Stocks Moving in Thursday's Pre-Market Session
- benzinga.com 60 Stocks Moving In Tuesday's Mid-Day Session
- benzinga.com 51 Biggest Movers From Yesterday
- benzinga.com 40 Biggest Movers From Yesterday
- benzinga.com Earnings Scheduled For March 13, 2014